These TGF‐β enhancers could be used to prevent and treat the majority (carcinoma) of human cancers,69 and other chronic inflammatory diseases such as atherosclerotic cardiovascular disease (ASCVD).77, 78. Here, TGFB1 is linked to carcinoma.